x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- Blumberg, LucilleRemove Blumberg, Lucille filter
- 2017 - 2022Remove 2017 - 2022 filter
Author
- Petersen, Eskild4
- Al-Abri, Seif3
- Abubakar, Aisha2
- Kock, Richard2
- Kramer, Laura D2
- Lee, Shui Shan2
- Ntoumi, Francine2
- Aklillu, Eleni1
- Ansumana, Rashid1
- Asogun, Danny1
- Azhar, Esam I1
- Azhar, Esam Ibraheem1
- Bates, Matthew1
- Bockarie, Moses1
- Chakaya, Jeremiah1
- Chen, Lin H1
- Edwards, Sarah1
- Go, Unyeong1
- Haider, Najmul1
- Hamer, Davidson H1
- Hamid, Muzamil Mahdi Abdel1
- Himwaze, Cordelia M1
- Holmes, Allison1
- Holmes, Allison H1
Coronavirus (COVID-19) Collection
4 Results
- EditorialOpen Access
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
International Journal of Infectious DiseasesVol. 114p268–272Published online: December 1, 2021- Eskild Petersen
- Francine Ntoumi
- David S Hui
- Aisha Abubakar
- Laura D. Kramer
- Christina Obiero
- and others
Cited in Scopus: 87Nearly two years since the start of the SARS-CoV-2 pandemic, which has caused over 5 million deaths, the world continues to be on high COVID-19 alert. The World Health Organization (WHO), in collaboration with national authorities, public health institutions and scientists have been closely monitoring and assessing the evolution of SARS-CoV-2 since January 2020 (WHO 2021a; WHO 2021b). The emergence of specific SARS-CoV-2 variants were characterised as Variant of Interest (VOI) and Variant of Concern (VOC), to prioritise global monitoring and research, and to inform the ongoing global response to the COVID-19 pandemic. The WHO and its international sequencing networks continuously monitor SARS-CoV-2 mutations and inform countries about any changes that may be needed to respond to the variant, and prevent its spread where feasible. - Letter to the EditorOpen Access
Answer to Paredes et al. commenting on “COVID-19 vaccines under the International Health Regulations — We must use the WHO International Certificate of Vaccination or Prophylaxis”
International Journal of Infectious DiseasesVol. 105p409–410Published online: February 23, 2021- Eskild Petersen
- Daniel Lucey
- Lucille Blumberg
- Laura D. Kramer
- Seif Al-Abri
- Shui Shan Lee
- Tatiana de Castro Abreu Pinto
- Christina W. Obiero
- Alfonso J. Rodriguez-Morales
- Richard Yapi
- Aisha Abubakar
- Paul Anantharajah Tambyah
- Allison Holmes
- Lin H. Chen
Cited in Scopus: 0We thank Dr Paredes et al. for their comment to our editorial (Petersen et al., 2021) on the potential use of International Health Regulations (IHR) and immunizations against SARS-CoV-2. - PerspectiveOpen Access
COVID-19–We urgently need to start developing an exit strategy
International Journal of Infectious DiseasesVol. 96p233–239Published online: April 28, 2020- Eskild Petersen
- Sean Wasserman
- Shui-Shan Lee
- Unyeong Go
- Allison H. Holmes
- Seif Al-Abri
- and others
Cited in Scopus: 48With the SARS-CoV-2 pandemic passing one million ill people (1,521,252 confirmed cases and 92 798 reported deaths (WHO Sit Rep 10 April), most countries are occupied with controlling the outbreak. The economic consequences are enormous. The World Trade Organization (WTO) estimates that “commerce could shrink up to 32% and warns against 30s-style protectionism” [WTO, 2020]. - EditorialOpen Access
Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak
International Journal of Infectious DiseasesVol. 93p205–207Published online: March 3, 2020- Eskild Petersen
- David Hui
- Davidson H. Hamer
- Lucille Blumberg
- Lawrence C. Madoff
- Marjorie Pollack
- Shui Shan Lee
- Susan McLellan
- Ziad Memish
- Ira Praharaj
- Sean Wasserman
- Francine Ntoumi
- Esam Ibraheem Azhar
- Timothy D. Mchugh
- Richard Kock
- Guiseppe Ippolito
- Ali Zumla
- Marion Koopmans
Cited in Scopus: 45Dr Li Wenliang, who lost his life to the novel coronavirus, SARS-CoV-2, became the face of the threat of SARS-CoV-2 to frontline workers, the clinicians taking care of patients. Li, 34, was an ophthalmologist at Wuhan Central Hospital. On 30th December, 2019, when the Wuhan municipal health service sent out an alert, he reportedly warned a closed group of ex-medical school classmates on the WeChat social media site of “Seven cases of severe acute respiratory syndrome (SARS) like illness with links with the Huanan Seafood Wholesale Market” at his hospital.